Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six

Go back to Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six
(NASDAQ: WVE) Delayed: 6.04 -0.13 (2.11%)
Previous Close $6.17    52 Week High $38.50 
Open $6.18    52 Week Low $8.95 
Day High $6.31    P/E N/A 
Day Low $6.02    EPS $0.00 
Volume 2,363,585       

(NASDAQ: WVE) Delayed: 6.04 -0.13 (2.11%)
Previous Close $6.17    52 Week High $38.50 
Open $6.18    52 Week Low $8.95 
Day High $6.31    P/E N/A 
Day Low $6.02    EPS $0.00 
Volume 2,363,585